1-5 of 5
Benedetto Farsaci
Close
Sort by
Journal Articles

Expression of Major Histocompatibility Complex (MHC) Class II, but Not MHC Class I, Predicts Outcome in Patients with Classical Hodgkin Lymphoma (cHL) Treated with Nivolumab (Programmed Death-1 [PD-1] Blockade)

Margaretha G.M. Roemer, MSc, Robert A. Redd, MS, Fathima Zumla Cader, MD PhD MRCP, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Stephanie Sasse, MD, Anas Younes, MD, Michelle A. Fanale, MD, Armando Santoro, MD, Pier Luigi Zinzani, MD, John M Timmerman, MD, Graham Collins, MD PhD, Rod Ramchandren, MD, Jonathon B Cohen, MDMS, Jan Paul De Boer, MD PhD, John Kuruvilla, MD, Kerry J Savage, BSc, MD MSc, Marek Trneny, MD, Stephen M Ansell, MD PhD, Mariana Sacchi, Benedetto Farsaci, MD, Anne Sumbul, Philippe Armand, MD PhD, Donna S. Neuberg, ScD, Geraldine S. Pinkus, Azra H. Ligon, Scott J. Rodig, MDPhD, Margaret A. Shipp, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1450.
https://doi.org/10.1182/blood.V130.Suppl_1.1450.1450
Published: 2017
Journal Articles

A Phase 1 Study of Nivolumab in Combination with Ipilimumab for Relapsed or Refractory Hematologic Malignancies (CheckMate 039)

Stephen Ansell, MD PhD, Martin E Gutierrez, MD, Margaret A. Shipp, MD, Douglas Gladstone, MD, Alison Moskowitz, Ivan Borello, Mihaela Popa-Mckiver, Benedetto Farsaci, Lili Zhu, MS, Alexander M. Lesokhin, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2016) 128 (22): 183.
https://doi.org/10.1182/blood.V128.22.183.183
Published: 2016
Journal Articles

Chromosome 9p24.1/ PD-L1 / PD-L2 Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade)

Margaretha G M Roemer, Azra H. Ligon, PhD, Andreas Engert, MD, Anas Younes, MD, Armando Santoro, Pier Luigi Zinzani, MD PhD, John M. Timmerman, MD, Stephen Ansell, MD PhD, Philippe Armand, MD PhD, Michelle A Fanale, MD, Voravit Ratanatharathorn, MD, John Kuruvilla, MD, Jonathon B. Cohen, MD, Graham P. Collins, MD PhD, Kerry J Savage, MD, Marek Trneny, Donna S. Neuberg, ScD, Robert A Redd, MS, Benedetto Farsaci, Kazunobu Kato, MD, Anne Sumbul, Scott J Rodig, Margaret A. Shipp, MD
Journal: Blood
Blood (2016) 128 (22): 2923.
https://doi.org/10.1182/blood.V128.22.2923.2923
Published: 2016
Journal Articles

Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

Giuseppe Milone, MD, Benedetto Farsaci, MD, Giuseppe Avola, BD, Salvatore Mercurio, BD, Aurora Strano, BD, Maria Grazia Camuglia, BD, Valeria Pinto, MD, Antonella Privitera, BD, Salvatore Leotta, MD, Massimo Poidomani, MD, Stefania Coppoletta, MD, Elisa Mauro, MD, Pamela Murgano, MD, Katia Battiato, MD, Andrea Spataro, MD, Anna Triolo, MD, Rosario Giustolisi, MD
Journal: Blood
Blood (2007) 110 (11): 2849.
https://doi.org/10.1182/blood.V110.11.2849.2849
Published: 2007
Journal Articles

Adverse Events after Infusions of Cryopreserved Hematopoietic Stem Cells Depend on Non-Mononuclear Cell in Infused Suspension and on Patient Age.

Giuseppe Milone, MD, Valeria Pinto, MD, Salvatore Mercurio, MD, Aurora Strano, MD, Stefania Coppoletta, MD, Benedetto Farsaci, MD, Massimo Poidomani, MD, Salvatore Leotta, MD, Rosario Giustolisi, Md
Journal: Blood
Blood (2006) 108 (11): 5244.
https://doi.org/10.1182/blood.V108.11.5244.5244
Published: 2006